Literature DB >> 28754776

The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis.

Dai-Min Xiang1,2,3, Wen Sun1, Bei-Fang Ning4, Teng-Fei Zhou1, Xiao-Feng Li1, Wei Zhong5, Zhuo Cheng1, Ming-Yang Xia1, Xue Wang1, Xing Deng4, Wei Wang4,6, Heng-Yu Li1, Xiu-Liang Cui1, Shi-Chao Li1, Bin Wu7, Wei-Fen Xie4, Hong-Yang Wang1,3, Jin Ding1,3.   

Abstract

BACKGROUND AND AIMS: Liver fibrosis is a wound-healing response that disrupts the liver architecture and function by replacing functional parenchyma with scar tissue. Recent progress has advanced our knowledge of this scarring process, but the detailed mechanism of liver fibrosis is far from clear.
METHODS: The fibrotic specimens of patients and HLF (hepatic leukemia factor)PB/PB mice were used to assess the expression and role of HLF in liver fibrosis. Primary murine hepatic stellate cells (HSCs) and human HSC line Lx2 were used to investigate the impact of HLF on HSC activation and the underlying mechanism.
RESULTS: Expression of HLF was detected in fibrotic livers of patients, but it was absent in the livers of healthy individuals. Intriguingly, HLF expression was confined to activated HSCs rather than other cell types in the liver. The loss of HLF impaired primary HSC activation and attenuated liver fibrosis in HLFPB/PB mice. Consistently, ectopic HLF expression significantly facilitated the activation of human HSCs. Mechanistic studies revealed that upregulated HLF transcriptionally enhanced interleukin 6 (IL-6) expression and intensified signal transducer and activator of transcription 3 (STAT3) phosphorylation, thus promoting HSC activation. Coincidentally, IL-6/STAT3 signalling in turn activated HLF expression in HSCs, thus completing a feedforward regulatory circuit in HSC activation. Moreover, correlation between HLF expression and alpha-smooth muscle actin, IL-6 and p-STAT3 levels was observed in patient fibrotic livers, supporting the role of HLF/IL-6/STAT3 cascade in liver fibrosis.
CONCLUSIONS: In aggregate, we delineate a paradigm of HLF/IL-6/STAT3 regulatory circuit in liver fibrosis and propose that HLF is a novel biomarker for activated HSCs and a potential target for antifibrotic therapy. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Hepatic leukemia factor; Hepatic stellate cell; IL-6; Liver fibrosis; STAT3

Mesh:

Substances:

Year:  2017        PMID: 28754776     DOI: 10.1136/gutjnl-2016-313392

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  57 in total

1.  Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis.

Authors:  Chen Qu; Dandan Zheng; Sai Li; Yingjun Liu; Anna Lidofsky; Jacinta A Holmes; Jianning Chen; Lu He; Lan Wei; Yadi Liao; Hui Yuan; Qimeng Jin; Zelong Lin; Qiaoting Hu; Yuchuan Jiang; Mengxian Tu; Xijun Chen; Weiming Li; Wenyu Lin; Bryan C Fuchs; Raymond T Chung; Jian Hong
Journal:  Hepatology       Date:  2018-05-21       Impact factor: 17.425

2.  Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer.

Authors:  Peter Dietrich; Laura Wormser; Valerie Fritz; Tatjana Seitz; Monica De Maria; Alexandra Schambony; Andreas E Kremer; Claudia Günther; Timo Itzel; Wolfgang E Thasler; Andreas Teufel; Jonel Trebicka; Arndt Hartmann; Markus F Neurath; Stephan von Hörsten; Anja K Bosserhoff; Claus Hellerbrand
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

3.  miR-219 regulates liver cancer stem cell expansion via E-cadherin pathway.

Authors:  Anfeng Si; Longqi Wang; Kun Miao; Rongrong Zhang; Huiyu Ji; Zhengqing Lei; Zhangjun Cheng; Xiangchun Fang; Baobing Hao
Journal:  Cell Cycle       Date:  2019-11-14       Impact factor: 4.534

4.  RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells.

Authors:  Zili Zhang; Mei Guo; Yujia Li; Min Shen; Desong Kong; Jiangjuan Shao; Hai Ding; Shanzhong Tan; Anping Chen; Feng Zhang; Shizhong Zheng
Journal:  Autophagy       Date:  2019-11-11       Impact factor: 16.016

5.  Mitochondrial dysfunction attenuates rapid regeneration in livers with toxin-induced fibrosis.

Authors:  Zheyong Li; Yuelong Liang; Hanning Ying; Mingyu Chen; Xiaoyan He; Yifan Wang; Yifan Tong; Xiujun Cai
Journal:  Ann Transl Med       Date:  2021-04

6.  Activation of Hepatic Stellate Cells Requires Dissociation of E-Cadherin-Containing Adherens Junctions with Hepatocytes.

Authors:  Hayato Urushima; Hideto Yuasa; Tsutomu Matsubara; Noriyuki Kuroda; Yaiko Hara; Kouji Inoue; Kenjiro Wake; Tetsuji Sato; Scott L Friedman; Kazuo Ikeda
Journal:  Am J Pathol       Date:  2020-12-18       Impact factor: 4.307

7.  HJC0416 Attenuates Fibrogenesis in Activated Hepatic Stellate Cells via STAT3 and NF-κB Pathways.

Authors:  Christian Sommerhalder; Claire B Cummins; Xiaofu Wang; Divya Ramdas; Omar Nunez Lopez; Yanping Gu; Jia Zhou; Ravi S Radhakrishnan
Journal:  J Surg Res       Date:  2021-01-21       Impact factor: 2.192

8.  miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients.

Authors:  Ze-Bin Jiang; Bing-Qiang Ma; Zongfeng Feng; Shao-Guang Liu; Peng Gao; Hui-Ting Yan
Journal:  Cell Cycle       Date:  2021-01-18       Impact factor: 4.534

Review 9.  Liver regeneration and inflammation: from fundamental science to clinical applications.

Authors:  Lara Campana; Hannah Esser; Meritxell Huch; Stuart Forbes
Journal:  Nat Rev Mol Cell Biol       Date:  2021-06-02       Impact factor: 94.444

10.  Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway.

Authors:  Hao Ruan; Jiaoyan Luan; Shaoyan Gao; Shuangling Li; Qiuyan Jiang; Rui Liu; Qing Liang; Ruiqin Zhang; Fangxia Zhang; Xiaohe Li; Honggang Zhou; Cheng Yang
Journal:  Molecules       Date:  2021-07-26       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.